Clinical Trials Logo

Glucose, High Blood clinical trials

View clinical trials related to Glucose, High Blood.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04846751 Enrolling by invitation - Glucose, High Blood Clinical Trials

Exercise Type That Faster Reduces Postprandial Glycemia.

GLYEXER
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

It is well established that a bout of 50 min of continuous moderate intensity exercise, improves insulin sensitivity up to 48 hours after the bout. However, it is less well known, what is the exercise type more efficient to buffer the elevations in blood glucose elicited by carbohydrate ingestion. The purpose of this study is to elucidate if intervalic exercise is superior to continous on improving postprandial glycemic control.

NCT ID: NCT04230694 Enrolling by invitation - Diabetes Clinical Trials

Continuous Glucose Monitoring of Hospitalized Patients With Diabetes

Start date: September 20, 2021
Phase: N/A
Study type: Interventional

Systematic continuous glucose monitoring (CGM) is commonly provided as a treatment option to patients with diabetes in ambulatory care settings yet is rarely provided during hospitalization. CGM of inpatients has the potential to be the care delivery innovation that is feasible, cost effective and can improve glucose control, especially by reducing hypoglycemic events. Studies of CGM use in the ICU setting have been found to be helpful for reducing hypoglycemia in some studies while less so in others, however, these studies were performed with earlier generation glucose monitoring devices(5). ICU studies have confirmed accuracy of CGM measurements compared with capillary glucose even in settings with use of vasopressors and large-volume resuscitation. A limited number of studies have evaluated glycemic outcomes in the inpatient non-ICU setting. Studies of non-ICU patients (6-10) are limited by very small sample size, short study duration, and use of older CGM devices. There is, therefore, a critical need to systematically investigate the use of CGM in the inpatient care of patients with diabetes mellitus who are receiving care in a hospital setting that is typical of inpatient care.